1. | blueboots70 | |
2. | ash68th |
1. | blueboots70 | |
2. | ash68th |
1. | blueboots70 05/15/2018 Reports Q1 net loss of €11.7M |
2. | ash68th 06/04/2018 ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018 |
3. | blueboots70 03/14/2018 Reports FY net loss of €33.53M |